Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Morgensztern

Showing results (11-20 of 184) with videos related to

Pageof 19
Sort By:
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Chemotherapy for Advanced-Stage Non-Small Cell Lung CancerLingling Du, Daniel Morgensztern
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2010
Best of the month: a roundup of articles published in recent monthsDaniel Morgensztern, Ramaswamy Govindan
Expert Review of Anticancer Therapy|April 15, 2006
Clinical trials of antiangiogenic therapy in non-small cell lung cancer: focus on bevacizumab and ZD6474Daniel Morgensztern, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2012
Miscellaneous agentsDaniel Morgensztern, Roy S Herbst
Current Treatment Options in Oncology|June 22, 2005
Molecular prognostic factors in diffuse large B-cell lymphomaDaniel Morgensztern, Izidore S Lossos
Anti-Cancer Drugs|August 13, 2005
PI3K/Akt/mTOR pathway as a target for cancer therapyDaniel Morgensztern, Howard L McLeod
Hematology/Oncology Clinics of North America|December 4, 2016
Evolving Treatment Options for Lung CancerDaniel Morgensztern, Roy S Herbst
Journal of Thoracic Disease|January 10, 2017
Precision medicine in lung cancer: the battle continuesSaiama N Waqar, Daniel Morgensztern
Expert Review of Clinical Immunology|June 9, 2015
Immunotherapy for non-small cell lung cancer: are we on the cusp of a new era?Saiama N Waqar, Daniel Morgensztern
Clinical Lymphoma|September 30, 2004
Non-Hodgkin's lymphoma in the microarray eraIzidore S Lossos, Daniel Morgensztern
Pageof 19

Showing results (11-20 of 184) with videos related to

Sort By:
Pageof 19
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Chemotherapy for Advanced-Stage Non-Small Cell Lung CancerLingling Du, Daniel Morgensztern
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2010
Best of the month: a roundup of articles published in recent monthsDaniel Morgensztern, Ramaswamy Govindan
Expert Review of Anticancer Therapy|April 15, 2006
Clinical trials of antiangiogenic therapy in non-small cell lung cancer: focus on bevacizumab and ZD6474Daniel Morgensztern, Ramaswamy Govindan
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2012
Miscellaneous agentsDaniel Morgensztern, Roy S Herbst
Current Treatment Options in Oncology|June 22, 2005
Molecular prognostic factors in diffuse large B-cell lymphomaDaniel Morgensztern, Izidore S Lossos
Anti-Cancer Drugs|August 13, 2005
PI3K/Akt/mTOR pathway as a target for cancer therapyDaniel Morgensztern, Howard L McLeod
Hematology/Oncology Clinics of North America|December 4, 2016
Evolving Treatment Options for Lung CancerDaniel Morgensztern, Roy S Herbst
Journal of Thoracic Disease|January 10, 2017
Precision medicine in lung cancer: the battle continuesSaiama N Waqar, Daniel Morgensztern
Expert Review of Clinical Immunology|June 9, 2015
Immunotherapy for non-small cell lung cancer: are we on the cusp of a new era?Saiama N Waqar, Daniel Morgensztern
Clinical Lymphoma|September 30, 2004
Non-Hodgkin's lymphoma in the microarray eraIzidore S Lossos, Daniel Morgensztern
Pageof 19